Research & Outcomes

stroke_outcomes_webPositive patient outcomes are vitally important, and the stroke team at O’Connor Hospital is committed to the following assessments, treatments and research studies for our stroke patients:

  • Fiberoptic Endoscopic Evaluation of Swallowing (FEES):  This is an instrumental assessment tool used by our trained speech language pathologists for evaluating and treating dysphagia in patients. The assessment is performed at the bedside.
  • Vital Stim: This treatment modality is used by our speech language pathologists in our outpatient setting to treat patients with dysphagia as an adjunct for retraining their swallowing function.
  • Platelet-Oriented Inhibition in New TIA (POINT) Clinical Trial: The purpose of this nationwide study is to determine the safety and effectiveness of the combination of low-dose aspirin and a medication called clopidogrel (also known by the brand name Plavix®) in reducing the risk of stroke, heart attacks and other complications in patients who have just had a TIA or minor ischemic stroke.

Surviving a stroke is a trying experience for both survivors’ and caregivers. O’Connor Hospital is proud to offer a peer stroke visitation program, where volunteer stroke survivors visit stroke patients in the hospital to provide support and resources.

O’Connor Hospital is a proud member of the California Stroke Registry, Paul Coverdell National Acute Stroke Registry and the American Stroke Associations Get with the Guidelines Quality Stroke Initiatives.